This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Alberta. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Innovations by Peter John Meloncelli
Introduction
Peter John Meloncelli is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of immunology through his innovative research and patent. His work focuses on methods and systems for inducing immunologic tolerance to non-self antigens, which has important implications for transplantation and immunotherapy.
Latest Patents
Meloncelli holds a patent for "Methods and systems for inducing immunologic tolerance to non-self antigens." This patent describes methods and systems that can be used to induce immunologic tolerance to non-self antigens. The methods involve introducing a tolerogen that comprises at least one immunogenic non-self antigen coupled to a carrier. The immunogenic antigen can be a foreign or endogenous antigen or fragments thereof. The non-self antigen can be selected from carbohydrate antigens, full-length antigenic proteins, and fragments and combinations thereof. The carrier can be selected from nanoparticles and stents. Tolerogen compositions are also provided and can be used to induce immunologic tolerance to non-self antigens. These methods, systems, and compositions are particularly advantageous as they can extend the window of safety for immunologically-incompatible transplantations to patients who are growing past the age of infancy. Meloncelli has 1 patent to his name.
Career Highlights
Peter John Meloncelli is affiliated with the University of Alberta, where he conducts his research. His work has garnered attention for its potential to improve outcomes in transplantation and immunotherapy.
Collaborations
Some of his notable coworkers include Lori Jeanne West and Todd Lambert Lowary, who have collaborated with him on various research projects.
Conclusion
Peter John Meloncelli's innovative work in immunology and his patent for inducing immunologic tolerance highlight his contributions to the field. His research has the potential to significantly impact transplantation practices and improve patient outcomes.